Literature DB >> 7875465

Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome.

Y Benhamou1, N Kapel, C Hoang, H Matta, D Meillet, D Magne, M Raphael, M Gentilini, P Opolon, J G Gobert.   

Abstract

BACKGROUND/AIMS: An alteration of the secretory immune response has been forwarded to explain frequent and chronic mucosal infections in patients with acquired immunodeficiency syndrome (AIDS). The aim of this study was to explore the intestinal immunoglobulin (Ig) secretions in patients with AIDS and their relationships to cryptosporidiosis.
METHODS: Patients with AIDS and enteric cryptosporidiosis (n = 12), other enteric infections (n = 10), and no identifiable enteric pathogen (n = 10) and human immunodeficiency virus-seronegative controls (n = 18) were studied. The number of intestinal IgA and IgM plasma cells of the duodenal lamina propria mucosa and total and anti-Cryptosporidium IgA, IgM, and IgG were measured in serum and feces.
RESULTS: Although not significantly increased, the number of IgA and IgM plasma cells was greater in patients with AIDS (n = 20) than in controls (n = 5). In feces, total IgA outputs and specific anti-Cryptosporidium IgA levels were significantly higher in patients with AIDS and cryptosporidiosis than in the two other groups of patients with AIDS (P < 0.05 and P < 0.01, respectively) and controls (P < 0.001 and P < 0.01, respectively). Total fecal IgM output and specific anti-Cryptosporidium IgM coproantibodies were increased only in the Cryptosporidium-infected patients relative to the controls (P < 0.05).
CONCLUSIONS: Despite the development of pathogen-specific mucosal antibody responses, patients with AIDS and cryptosporidiosis fail to clear the parasite.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875465     DOI: 10.1016/0016-5085(95)90433-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

2.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

3.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

4.  Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model.

Authors:  G J Leitch; Q He
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Evidence of thymus-independent local and systemic antibody responses to Cryptosporidium parvum infection in nude mice.

Authors:  A A Adjei; J T Jones; M W Riggs; F J Enriquez
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion.

Authors:  James K Roche; Ana Lara Rojo; Lourrany B Costa; Ronald Smeltz; Patricio Manque; Ute Woehlbier; Luther Bartelt; James Galen; Gregory Buck; Richard L Guerrant
Journal:  Vaccine       Date:  2012-12-16       Impact factor: 3.641

8.  Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.

Authors:  L Belec; D Meillet; O Gaillard; T Prazuck; E Michel; J Ngondi Ekome; J Pillot
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.

Authors:  Chan-Gu Surl; Hyeon-Cheol Kim
Journal:  J Vet Sci       Date:  2006-03       Impact factor: 1.672

10.  Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients.

Authors:  Kirti Kaushik; Sumeeta Khurana; Ajay Wanchu; Nancy Malla
Journal:  BMC Infect Dis       Date:  2009-11-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.